Foxkiser is a venture capital firm focused on innovation at the intersection of science, law and medicine, with a 40-year history backing life sciences and adjacent regulated sectors. It has acted as a lead investor in a U.S. Series A round, making it relevant for early-stage founders in biotechnology, pharmaceuticals, medical devices, HealthTech, wellness and select gaming applications tied to health outcomes.